76450-TD

Welcome and Opening Session: Pharmaceutical Treatment of Presbyopia

Thursday, March 17, 2022

9:00 AM – 9:55 AM ET

Presenter(s)

Marguerite B. McDonald, MD, FACS

Associate
OCLI
NYU Langone Medical Center
Port Washington, New York
Lisa Nijm, MD, JD

Founder and Medical Director
Warrenville EyeCare and LASIK
University of Illinois Eye and Ear Infirmary
Warrenville, Illinois

Presbyopia---both corrected and uncorrected---takes a great economic and human toll on society. There are numerous eye drops that are designed to treat presbyopia; some contain one active ingredient, while others contain two or more. One drop is FDA approved, and the rest are in the pipeline. The advantages and disadvantages of each will be presented.

Learning Objectives:

Attendees will be familiar with the substantial economic and human costs to society of presbyopia
Attendees will learn which eye drops are available or in the pipeline for the treatment of presbyopia